Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000528680 | SCV000651713 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000574032 | SCV000671958 | likely benign | Hereditary cancer-predisposing syndrome | 2017-04-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000574032 | SCV000691303 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001264518 | SCV001442712 | likely benign | not specified | 2020-10-22 | criteria provided, single submitter | clinical testing |